LOS ANGELES -- In the PRESTIGE-AF trial, survivors of intracerebral hemorrhage (ICH) had good protection against future ischemic events using direct oral anticoagulants (DOACs) -- though, as feared, ...
The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke, according to preliminary ...
In any case, there was no mortality signal associated with alteplase administered up to 24 hours after a stroke in HOPE.
Use of endovascular thrombectomy in patients with acute ischemic stroke caused by occlusions in distal vessels has failed to ...
More than 100 million people globally have had a stroke, but there are ways to reduce your risk and spot the signs of stroke ...
A new study suggests that a simple blood test could help emergency responders quickly determine whether a stroke is caused by ...
(Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the world's first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system-the ...
Three trials showed no improvement in functional outcomes, and the potential for harm, versus medical therapy alone.
Mechanically retrieving a blood clot blocking a medium- or small-sized brain artery was no better at reducing disability 90 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback